(Q34511954)

2 August 2017

Hepatocellular carcinoma in central Sydney:a 10-year review of patients seen in a medical oncology department (English)

1 reference

2 August 2017

hepatocellular carcinoma

1 reference

1 reference

Desmond Yip

1

1 reference

ORCID Public Data File 2021

author name string

Michael Findlay

series ordinal

2

1 reference

2 August 2017

Michael Boyer

series ordinal

3

1 reference

2 August 2017

Martin H Tattersall

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

World Journal of Gastroenterology

2 August 2017

1 reference

2 August 2017

5

1 reference

2 August 2017

6

1 reference

2 August 2017

483-487

1 reference

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

Current treatment modalities for hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

Prognostic factors for survival in hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

Treatment of small hepatocellular carcinomas

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4688790

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

27 October 2018

1 reference

12 December 2020

Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma

1 reference

12 December 2020

Chemohormonal therapy of unresectable hepatocellular carcinoma

1 reference

12 December 2020

Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial

1 reference

12 December 2020

Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen

1 reference

12 December 2020

Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18-29 (1999)

1 reference

12 December 2020

Controlled clinical trial of doxorubicin and tamoxifen versus doxorubicin alone in hepatocellular carcinoma

1 reference

12 December 2020

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V5.I6.483

0 references

PMCID

4688790

1 reference

2 August 2017

1 reference